FONT-SIZE Plus   Neg

Abbott Labs Q1 Profit Rises; Lifts FY12 Profit View - Quick Facts

Abbott Laboratories (ABT) reported that its first-quarter net earnings rose to $1.24 billion or $0.78 per share, from $864 million or $0.55 per share in the same quarter last year.

Excluding Specified Items, net earnings for the quarter were $1.65 billion or $1.03 per share, up from $1.42 billion or $0.91 per share last year. Analysts polled by Thomson Reuters expected the company to report earnings of $1.00 per share. Analysts' estimates typically exclude special items.

Net sales for the quarter rose to $9.46 billion from $9.04 billion in the prior year quarter. Sixteen analysts had consensus revenue estimate of $9.36 billion for the quarter.

Abbott raised its full-year 2012 ongoing earnings-per-share guidance to a range of $5.00 to $5.10 from the prior outlook of $4.95 to $5.05. Analysts expect the company to report earnings of $5.01 per share for fiscal 2012.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Apple confirmed that it has bought face animation software firm Faceshift, although it was tight lipped about how it intends to use the new addition. The move is speculated as a bid to expand into virtual reality. Environment ministry of South Korea Thursday ordered Volkswagen Korea to recall 125,522 diesel vehicles on determining actual emissions of nitrogen oxides. The ministry has asked the German automobile maker to pay a fine of 14.1 billion Won or $12.31 million. The company has to submit a recall plan by January 6, 2016. The U.S. Food and Drug Administration has alerted health care professionals and patients of a voluntary recall of compounded multivitamin capsules containing high amounts of Vitamin D3 (Cholecalciferol), distributed nationwide by Glades Drugs in Pahokee, Florida. FDA has received reports of several...
comments powered by Disqus
Follow RTT